{"id":45247,"date":"2022-06-20T12:01:45","date_gmt":"2022-06-20T10:01:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dxcover-launches-infrared-platform-ground-breaking-technology-for-faster-sample-analysis\/"},"modified":"2022-06-20T12:01:45","modified_gmt":"2022-06-20T10:01:45","slug":"dxcover-launches-infrared-platform-ground-breaking-technology-for-faster-sample-analysis","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dxcover-launches-infrared-platform-ground-breaking-technology-for-faster-sample-analysis\/","title":{"rendered":"Dxcover Launches Infrared Platform: Ground-Breaking Technology for Faster Sample Analysis"},"content":{"rendered":"
\n

\nDxcover\u00ae Infrared Platform enables high-speed, low-cost, and sensitive early detection of multiple cancers<\/i><\/b>\n<\/p>\n

DUBLIN–(BUSINESS WIRE)–Dxcover Limited<\/a>, a clinical stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the launch of the Dxcover\u00ae platform, a ground-breaking platform that transforms Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectroscopy to enable faster sample analysis. Dr. Matthew Baker, co-founder and Chief Technology Officer, will be presenting an overview of the technology at the 12th<\/sup> International Conference on Clinical Spectroscopy (SPEC) in Dublin, Ireland.\n<\/p>\n

<\/a><\/p>\n

\nATR-FTIR spectroscopy is a powerful analytical technique without the need for extensive sample preparation or use of reagents. The traditional ATR method is reliant upon an internal reflection element (IRE), which is often a fixed point of analysis that requires mandatory cleaning steps to avoid cross contamination.\n<\/p>\n

\nThe Dxcover Infrared Platform however is composed of novel hardware items that transform commercial FTIR instruments. Dxcover sample slides are made from microfabricated silicon wafers and replace the single IRE with four sampling areas for one background measurement, and three sample measurements. Additionally, the Dxcover Autosampler can automate sample slide analysis, indexing the slide across the infrared beam without user interaction. Alongside efficiencies in batch processing, the Dxcover approach can be four times faster than standard ATR-FTIR instrumentation, which is optimized for clinical applications.\n<\/p>\n

\n\u201cOur team is excited to unveil our platform\u2019s unique and innovative hardware at SPEC,\u201d said Dr. Baker. \u201cThis milestone marks a significant step forward in transforming the use of infrared spectroscopy for a whole host of applications including detecting cancer at an earlier stage, which maximizes the opportunity to combat or control disease progression.\u201d\n<\/p>\n

\nAbstracts being presented at SPEC include:\n<\/p>\n